Make a deal with Roche
🔒 Paid proposals held safely in escrow — released only when the work's approved.
Known for
4.8K views
Sleep should be a time of rest, not a time of risk.
"I think predictive technology gives us a lot more than just a safe sleep and better predictions. It also means more quality of life and not using this energy for the diabetes, but actually using it for things that matter to
3.8K views
Roche’s sequencing by expansion (SBX) technology is transforming DNA sequencing! By converting nucleotide bases into long molecules before it passes through microscopic pores, it scales up molecular signals into digital data.✨ #Biotech #Innovation
https://t.co/P4NOhxj8Ub
3.2K views
#MEDIA - Roche’s sequencing platform is now available for research use, capable of same‑day whole genome sequencing in research
workflows, demonstrating end‑to‑end whole‑genome results within hours. https://t.co/xFTCoZwDZr
#Genomics #HumanGenetics #RocheSBX #Innovation #NGS
3.1K views
#MEDIA – We are pleased to share that the CHMP has recommended approval of our continuous delivery treatment for adults with neovascular age-related macular degeneration (#nAMD) - the leading cause of blindness in people over 60. 👉 https://t.co/XQSDUcT8Ji
📊 Post performance
🔥 Top post: Sleep should be a time of rest, not a time of risk. "I think p · 4.8K views
📊 Activity & format
Recent posts
View on X ↗
🔥 Top post
Sleep should be a time of rest, not a time of risk.
"I think predictive technology gives us a lot more than just a safe sleep and better predictions. It also means more quality of life and not using this energy for the diabetes, but actually using it for things that matter to
#MEDIA – At #APVRS2026, we're pleased to share new two-year data for our treatment in patients with PCV, a severe sub-type of nAMD – the leading cause of vision loss in people over 60. https://t.co/9XpS4N4WXT
#MEDIA – We are pleased to share that the CHMP has recommended approval of our continuous delivery treatment for adults with neovascular age-related macular degeneration (#nAMD) - the leading cause of blindness in people over 60. 👉 https:/…
Roche’s sequencing by expansion (SBX) technology is transforming DNA sequencing! By converting nucleotide bases into long molecules before it passes through microscopic pores, it scales up molecular signals into digital data.✨ #Biotech #In…
#MEDIA – We are pleased to announce that the U.S. FDA has accepted Roche’s supplemental Biologics License Application, with priority review, in primary
#MembranousNephropathy
Read more here 👉 https://t.co/tezIhxaMRo
$ROG $RHHBY
The first fully automated diagnostic solution to identify the most severe form of viral hepatitis is finally here, helping clinicians address the urgent need for a consistent, widely accessible solution. https://t.co/9XpS4N4WXT
$RHHBY $R…
We're at #AAIC26! Come by booth to speak to our team about the latest advancements in Alzheimer’s. We look forward to meeting you! 👋
Just 19 minutes per patient to process. Under 24 hours to results. ⏱️ A new blood test for tuberculosis infection is giving labs the efficiency they need to handle growing global testing demands. Faster testing means we're one step closer …
#MEDIA – We are pleased to share that Roche presents new data in Alzheimer’s disease from across its integrated pharmaceutical and diagnostics portfolio at #AAIC26. Learn more 👉 https://t.co/9XpS4N4WXT
#MEDIA We are pleased to share that our Phase III study in advanced #KRAS G12C-positive #NSCLC met its primary endpoint, demonstrating positive top-line results. Read more here: https://t.co/xFTCoZwDZr
The Bundibugyo virus is a rare and deadly strain of #Ebola that often escapes detection by commonly used frontline tests. That’s why containing outbreaks while providing critical surveillance to monitor any further spread is vital. Our com…
#MEDIA - We are pleased that the US FDA has accepted the supplemental Biologics License Application (sBLA) for our investigational medicine for thyroid eye disease (TED).
👉 https://t.co/yQC1GJva21
💡 Facts
🕵️ Fake follower check
Estimated- Est. 66% real, active audience · Medium fake-follower risk.
- Low engagement (~1.0% of followers engage each post) — a sign of an inflated or inactive audience.
- Organic base — far more followers than accounts it follows.
- Established account (17+ years old).
- 0.01% engagement — below the ~14.4% typical for this size.
Heuristic estimate from engagement, follower ratios, account age & growth — a screening signal, not a guarantee.
About
📸 Gallery
🔀 Audience overlap
EstimatedEstimated shared audience with similar creators — useful for avoiding overlap (or doubling down) when planning a campaign.
Al Arabiya English
18%
子羊系VTuber金羊アリエ♈
16%
DIGITAL ART CENTER福岡
14%
ぶっぱげ/B-PAGE【Citrus】
12%
NewsChannel 5
11%
Stand With Crypto🛡️
11%
More like this
Find more →
Frequently asked questions
How much does Roche charge for a sponsorship?
How do I contact Roche for a brand deal or collaboration?
How many followers does Roche have?
✉ Message Roche
Reaching out to influencers is a Pro feature. Upgrade to message any influencer directly — perfect for brands and agencies booking sponsorships.
- ✓ Message any influencer from their listing
- ✓ The influencer gets notified by email
- ✓ Manage every conversation in one inbox
Already Pro? Log in.
🎤 Event / appearance with Roche
Booking an event / appearance is a Pro feature. Upgrade to book Roche for an in-person or virtual appearance — payment held safely in escrow until the event is done.
- ✓ Book them for events, livestreams, panels & more
- ✓ Roche gets notified by email
- ✓ Fee held in escrow, released after the appearance
Already Pro? Log in.
You're out of free requests this month
Free accounts get 5 per month. Go Pro for unlimited sponsor pitches, collab requests & sponsorship deals — plus featured placement, the Verified badge, free withdrawals and more.
Upgrade to Pro — $9.95/mo →Your free limit resets on the 1st of next month.
Auto-generated from X's public data — no affiliation with or endorsement by SocialDB. Is this you? Claim it · Remove